Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention

W. Yeh, Robert; A. Secemsky, Eric; J. Kereiakes, Dean; T. Normand, Sharon‐Lise; Gershlick, Anthony; J. Cohen, David; A. Spertus, John; Gabríel Steg, Philippe; E. Cutlip, Donald; J. Rinaldi, Michael; Camenzind, Edoardo; Wijns, William; Apruzzese, Patricia; Song, Yang; M. Massaro, Joseph; Mauri, Laura; the DAPT Study Investigators, for

doi:10.1001/jama.2016.3775

Public

Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention

Published in JAMA • Mar 29, 2016

Authors:

Robert W. Yeh

Eric A. Secemsky

Dean J. Kereiakes

Abstract

IMPORTANCE: Dual antiplatelet therapy after percutaneous coronary intervention (PCI) reduces ischemia but increases bleeding. OBJECTIVE: To develop a clinical decision tool to identify patients expected to derive benefit vs harm from continuing thienopyridine beyond 1 year after PCI. DESIGN, SETTING...

Subject

Medicine

Percutaneous coronary intervention

Conventional PCI

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!